Wu P, Filley A, Miller M, Bruce J
Adv Exp Med Biol. 2023; 1405:31-71.
PMID: 37452934
DOI: 10.1007/978-3-031-23705-8_2.
Rube C, Raid S, Palm J, Rube C
Cancers (Basel). 2023; 15(11).
PMID: 37296960
PMC: 10252014.
DOI: 10.3390/cancers15112999.
De Groot J, van Dijken B, van der Weide H, Enting R, van der Hoorn A
PLoS One. 2023; 18(5):e0275077.
PMID: 37134064
PMC: 10155950.
DOI: 10.1371/journal.pone.0275077.
Kirkman M, Day J, Gehring K, Zienius K, Grosshans D, Taphoorn M
Cochrane Database Syst Rev. 2022; 11:CD011335.
PMID: 36427235
PMC: 9697842.
DOI: 10.1002/14651858.CD011335.pub3.
Kirkman M, Hunn B, Thomas M, Tolmie A
Front Oncol. 2022; 12:943600.
PMID: 36033458
PMC: 9407441.
DOI: 10.3389/fonc.2022.943600.
Mid-term treatment-related cognitive sequelae in glioma patients.
Schlomer S, Felsberg J, Pertz M, Hentschel B, Loffler M, Schackert G
J Neurooncol. 2022; 159(1):65-79.
PMID: 35796933
PMC: 9325813.
DOI: 10.1007/s11060-022-04044-1.
Use of a Luciferase-Expressing Orthotopic Rat Brain Tumor Model to Optimize a Targeted Irradiation Strategy for Efficacy Testing with Temozolomide.
Mowday A, Lieuwes N, Biemans R, Marcus D, Rezaeifar B, Reniers B
Cancers (Basel). 2020; 12(6).
PMID: 32549357
PMC: 7352586.
DOI: 10.3390/cancers12061585.
Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma.
Lawrie T, Gillespie D, Dowswell T, Evans J, Erridge S, Vale L
Cochrane Database Syst Rev. 2019; 8:CD013047.
PMID: 31425631
PMC: 6699681.
DOI: 10.1002/14651858.CD013047.pub2.
Assessing behavioral syndromes in patients with brain tumors using the frontal systems behavior scale (FrSBe).
Cabrera S, Edelstein K, Mason W, Tartaglia M
Neurooncol Pract. 2019; 3(2):113-119.
PMID: 31386079
PMC: 6668266.
DOI: 10.1093/nop/npv055.
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary utility in adult neuro-oncology.
Loughan A, Braun S, Lanoye A
Neurooncol Pract. 2019; 6(4):289-296.
PMID: 31386070
PMC: 6660821.
DOI: 10.1093/nop/npy050.
Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapy.
Ajmal A, McKean E, Sullivan S, Barkan A
Pituitary. 2018; 21(6):624-630.
PMID: 30349995
DOI: 10.1007/s11102-018-0918-y.
[Cognitive deficits following brain tumor radiation therapy].
Buthut M, Haussmann R, Seidlitz A, Krause M, Donix M
Nervenarzt. 2017; 89(4):423-430.
PMID: 28932944
DOI: 10.1007/s00115-017-0423-y.
The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
Ryken T, Parney I, Buatti J, Kalkanis S, Olson J
J Neurooncol. 2015; 125(3):551-83.
PMID: 26530266
DOI: 10.1007/s11060-015-1948-1.
Health-related quality of life in high-grade glioma patients.
Dirven L, Aaronson N, Heimans J, Taphoorn M
Chin J Cancer. 2014; 33(1):40-5.
PMID: 24384239
PMC: 3905089.
DOI: 10.5732/cjc.013.10214.
Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study.
Froklage F, Oosterbaan L, Sizoo E, de Groot M, Bosma I, Sanchez E
J Neurooncol. 2013; 116(2):387-94.
PMID: 24264531
DOI: 10.1007/s11060-013-1310-4.
Neuropsychological functions and quality of life in survived patients with intracranial germ cell tumors after treatment.
Liang S, Yang T, Chen Y, Liang M, Chen H, Chang K
Neuro Oncol. 2013; 15(11):1543-51.
PMID: 24101738
PMC: 3813422.
DOI: 10.1093/neuonc/not127.
Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.
Klein M
Neuro Oncol. 2012; 14 Suppl 4:iv17-24.
PMID: 23095826
PMC: 3480241.
DOI: 10.1093/neuonc/nos161.
Development of a novel animal model to differentiate radiation necrosis from tumor recurrence.
Kumar S, Arbab A, Jain R, Kim J, deCarvalho A, Shankar A
J Neurooncol. 2012; 108(3):411-20.
PMID: 22407176
PMC: 3369018.
DOI: 10.1007/s11060-012-0846-z.
Cognition and resective surgery for diffuse infiltrative glioma: an overview.
Klein M, Duffau H, de Witt Hamer P
J Neurooncol. 2012; 108(2):309-18.
PMID: 22362370
PMC: 3351615.
DOI: 10.1007/s11060-012-0811-x.
Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy.
Scoccianti S, Detti B, Cipressi S, Iannalfi A, Franzese C, Biti G
J Neurooncol. 2012; 108(2):291-308.
PMID: 22354791
DOI: 10.1007/s11060-012-0821-8.